It has a wide range of activity against Gram-positive and Gram-negative bacteria.
The recommended dose rate in dogs is 5 - 10 mg/kg given once daily. Higher doses may result in phototoxicity and intravenous use may induce a histamin-release-induced QT prolongation.
- Malik R et al (2013) Ulcerated and nonulcerated nontuberculous cutaneous mycobacterial granulomas in cats and dogs. Vet Dermatol 24(1):146-153
- Govendir M et al (2011) Susceptibility of rapidly growing mycobacteria isolated from cats and dogs, to ciprofloxacin, enrofloxacin and moxifloxacin. Vet Microbiol 147(1-2):113-118
- Ledbetter EC et al (2007) In vitro fluoroquinolone susceptibility of Pseudomonas aeruginosa isolates from dogs with ulcerative keratitis. Am J Vet Res 68(6):638-642
- Patmore L et al (2000) Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration. Eur J Pharmacol 406(3):449-452